Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety
Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.
Read more on NPR
Health Care - September 26, 2020 at 05:18AM - Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety
Không có nhận xét nào:
Đăng nhận xét